Cover Image
Market Research Report

Cold And Flu Supplements Market Size, Share & Trends Analysis Report By Product (Natural Molecules, Herbal Extracts, Vitamins & Minerals), By Region, And Segment Forecasts, 2020 - 2027

Published by Grand View Research, Inc. Product code 937480
Published Content info 80 Pages
Delivery time: 2-3 business days
Price
Back to Top
Cold And Flu Supplements Market Size, Share & Trends Analysis Report By Product (Natural Molecules, Herbal Extracts, Vitamins & Minerals), By Region, And Segment Forecasts, 2020 - 2027
Published: May 13, 2020 Content info: 80 Pages
Description

Cold & Flu Supplements Market Growth & Trends

The global cold and flu supplements market size is expected to reach USD 23.11 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.6% over the forecast period. Rising health consciousness among the consumers has been driving the demand for cold and flu supplements across the world. Over the past few years, consumers have become better informed about seasonal diseases and their preventions. As a result, consumers are increasingly spending on preventive healthcare in order to limit the occurrences of cold and flu. This trend has widened the scope of cold and flu supplements across the globe.

Increasing producers' focus on product innovation, along with shifting consumers' preference towards natural products, has increased the opportunity for cold and flu supplements. Furthermore, rising purchasing power of the consumers is allowing them to spend more on products that help in preventing diseases and boosting immunity. This trend is expected to fuel the demand for cold and flu supplements in the upcoming years.

The vitamins and minerals product segment held the largest market share in 2019. Vitamin C, Vitamin D, and Zinc are the most consumed products among vitamins and minerals. These products help in preventing the illness and shortening its duration. Therefore, a large number of consumers have been consuming vitamins and minerals to avoid seasonal flu. The herbal extract products are projected to gain the most traction among the consumers in the upcoming years.

Asia Pacific led the market in 2019 with over 30.0% share of the global revenue. Increased spending on immunity boosting among the rising number of middle class groups in China and India has fueled the demand for the product in the region. Europe is anticipated to witness the fastest growth over the forecast period. Growing demand for natural products in the region is expected to create wide opportunities for the market.

Cold & Flu Supplements Market Report Highlights

In terms of product, the vitamins and minerals segment dominated the market with over 35.0% share of the global revenue owing to their increased consumption among the consumers

Herbal extract-based cold and flu supplements are expected to expand at the fastest CAGR of 6.9% from 2020 to 2027

Asia Pacific dominated the market in 2019 with more than 30.0% share of the global revenue. Rising spending on preventive healthcare among millennials in emerging economies, including China and India, is expected to have a positive impact on the regional industry growth

Europe is expected to register the fastest CAGR of 7.1% from 2020 to 2027 owing to growing demand for natural supplements in Germany, France, and U.K.

Table of Contents
Product Code: GVR-4-68038-249-5

Table of contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segmental Outlook
  • 2.3. Competitive Insights

Chapter 3. Cold & Flu Supplements Market Variables, Trends & Scope

  • 3.1. Market Introduction
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Sales/Retail Channel Analysis
    • 3.3.2. Profit Margin Analysis
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Industry Challenges
    • 3.4.4. Industry Opportunities
  • 3.5. Business Environment Analysis
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier Power
      • 3.5.1.2. Buyer Power
      • 3.5.1.3. Substitution Threat
      • 3.5.1.4. Threat from New Entrant
      • 3.5.1.5. Competitive Rivalry
  • 3.6. Roadmap of Cold & Flu Supplements Market
  • 3.7. Market Entry Strategies

Chapter 4. Consumer Behavior Analysis

  • 4.1. Consumer Trends and Preferences
  • 4.2. Factors Affecting Buying Decision
  • 4.3. Consumer Product Adoption
  • 4.4. Observations & Recommendations

Chapter 5. Cold & Flu Supplements Market: Product Estimates & Trend Analysis

  • 5.1. Product Movement Analysis & Market Share, 2019 & 2027
  • 5.2. Natural Molecules
    • 5.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
  • 5.3. Herbal Extracts
    • 5.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
  • 5.4. Vitamins & Minerals
    • 5.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 6. Cold & Flu Supplements Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Movement Analysis & Market Share, 2019 & 2027
  • 6.2. North America
    • 6.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.2.2. Market estimates and forecast, by product, 2016 - 2027 (USD Million)
    • 6.2.3. U.S.
      • 6.2.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 6.2.3.2. Market estimates and forecast, by product, 2016 - 2027 (USD Million)
  • 6.3. Europe
    • 6.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.3.2. Market estimates and forecast, by product, 2016 - 2027 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 6.3.3.2. Market estimates and forecast, by product, 2016 - 2027 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 6.3.4.2. Market estimates and forecast, by product, 2016 - 2027 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.4.2. Market estimates and forecast, by product, 2016 - 2027 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 6.4.3.2. Market estimates and forecast, by product, 2016 - 2027 (USD Million)
    • 6.4.4. Japan
      • 6.4.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 6.4.4.2. Market estimates and forecast, by product, 2016 - 2027 (USD Million)
  • 6.5. Central & South America
    • 6.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.5.2. Market estimates and forecast, by product, 2016 - 2027 (USD Million)
    • 6.5.3. Brazil
      • 6.5.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 6.5.3.2. Market estimates and forecast, by product, 2016 - 2027 (USD Million)
  • 6.6. Middle East & Africa (MEA)
    • 6.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.6.2. Market estimates and forecast, by product, 2016 - 2027 (USD Million)

Chapter 7. Competitive Analysis

  • 7.1. Key global players, recent developments & their impact on the industry
  • 7.2. Key Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 7.3. Vendor Landscape
    • 7.3.1. Key company market share analysis, 2019

Chapter 8. Company Profiles

  • 8.1. WAKUNAGA OF AMERICA CO., LTD.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Strategic Initiatives
  • 8.2. Neurobiologix, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Strategic Initiatives
  • 8.3. The Vitamin Shoppe
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Strategic Initiatives
  • 8.4. KLAIRE LABS
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Strategic Initiatives
  • 8.5. Pfizer Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Strategic Initiatives
  • 8.6. GlaxoSmithKline plc
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Strategic Initiatives
  • 8.7. Nordic Naturals
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Strategic Initiatives
  • 8.8. Himalaya Global Holdings Ltd.
    • 8.8.1. Company Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Strategic Initiatives
  • 8.9. Nature's Way Products, LLC (Dr. Willmar Schwabe GmbH & Co. KG)
    • 8.9.1. Company Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Strategic Initiatives
  • 8.10. FineVine
    • 8.10.1. Company Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Strategic Initiatives
  • 8.11. Flora Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Financial Performance
    • 8.11.3. Product Benchmarking
    • 8.11.4. Strategic Initiatives
  • 8.12. NOW Foods
    • 8.12.1. Company Overview
    • 8.12.2. Financial Performance
    • 8.12.3. Product Benchmarking
    • 8.12.4. Strategic Initiatives

List of Tables

  • 1. Cold & flu supplements - Key market driver analysis
  • 2. Cold & flu supplements - Key market restraint analysis
  • 3. Global natural molecules cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 4. Global herbal extracts cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 5. Global vitamins & minerals cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 6. North America cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 7. North America cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
  • 8. U.S. cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 9. U.S. cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
  • 10. Europe cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 11. Europe cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
  • 12. Germany cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 13. Germany cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
  • 14. France cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 15. France cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
  • 16. Asia Pacific cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 17. Asia Pacific cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
  • 18. China cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 19. China cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
  • 20. Japan cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 21. Japan cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
  • 22. Central & South America Cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 23. Central & South America cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
  • 24. Brazil cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 25. Brazil cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
  • 26. MEA cold & flu supplements market estimates and forecast, 2016 - 2027 (USD Million)
  • 27. MEA cold & flu supplements market revenue estimates and forecast by product, 2016 - 2027 (USD Million)
  • 28. Vendor landscape

List of Figures

  • 1. Cold & flu supplements market snapshot
  • 2. Cold & flu supplements market segmentation & scope
  • 3. Cold & flu supplements market penetration & growth prospect mapping
  • 4. Cold & flu supplements value chain analysis
  • 5. Cold & flu supplements market dynamics
  • 6. Cold & flu supplements market Porter's analysis
  • 7. Cold & flu supplements market: Product movement analysis
  • 8. Cold & flu supplements market: Regional movement analysis
Back to Top